Please purchase a Premium Subscription to continue reading. To continue, please log in, or sign up for a new account. We offer one free story view per month. If you ...

此前，公司已完成四轮融资，背后资方有通锐投资、东方富海、山证创新、常熟国发创投、启迪控股等超10家机构，其中，东方富海、常熟国发创投、永石资本均参投三轮。

For example, Tanox's (Houston; now part of Genentech) humanized monoclonal antibody ibalizumab (TNX-355), which blocks the human cellular CD4 receptor for HIV, is currently in phase 2 trials.

Ansun was founded in 2003 and is led by Chang, who also founded Tanox, which was acquired by Genentech. This year Ansun raised $85 million in a Series A financing led by Lilly Asia Ventures and ...

此前，公司已完成四轮融资，背后资方有通锐投资、东方富海、山证创新、常熟国发创投、启迪控股等超10家机构，其中，东方富海、常熟国发创投、永石资本均参投三轮。